I'm LongbridgeAI, I can summarize articles.Asymchem (6821.HK) surged more than 12% in Hong Kong trading, last at HK$120.30.
The stock is up 17.59% over the past six months and up 72.59% year to date. It sits 77.70% above its 52-week low of HK$67.70. The intraday swing reached 12.48%.
The Hang Seng Index is up 2.90% over the past five sessions and down 7.28% year to date.
The pharmaceuticals industry index rose 1.6% over the same period.
The company reported third-quarter 2026 revenue of approximately 1.788 billion yuan, up 24.04% from a year earlier; net income rose 81.49% to about 332 million yuan. Asymchem said newly signed orders maintained double-digit growth and expects a significant increase in fourth-quarter delivery volume, guiding to full-year revenue growth of 19% to 22%.
For the first nine months, revenue totaled approximately 5.395 billion yuan, up 16.52% year-over-year; net income attributable to shareholders was about 852 million yuan, a gain of 6.49%, with basic earnings per share of 2.36 yuan. Bernstein previously raised its price target for the stock.
Based on public media reports. AI-generated; not investment advice.
